STOCK TITAN

ReShape Lifesciences, Inc. (RSLS) Revenue by Year

RSLS

ReShape Lifesciences, Inc. generated $320K in revenue in fiscal year 2025. This represents an increase of 24.4% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters ReShape Lifesciences, Inc. has filed alongside them.

FY2025 annual
Revenue $320K
YoY +24.4%
5Y CAGR -51.0%
10Y CAGR -22.4%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RSLS Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
Revenue$320K+24.4%$257K-97.0%$8.7M-22.8%$11.2M-17.4%$13.6M+20.4%$11.3M+244.4%$3.3M-63.9%$9.1M-8.2%$9.9M+192.2%$3.4M-16.0%$4.0M+14.1%$3.5M

RSLS Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'25Q2'2510-QQ1'2510-QQ4'2410-KQ3'24Q2'2410-QQ1'24Q4'23Q3'23Q2'23
Revenue$32K-84.1%N/A$35K-59.0%$1.2M-36.8%$199K-89.8%N/A$85K-96.1%$2.0M-12.8%$1.9M-15.0%$2.0M-36.3%$2.2M-23.0%$2.3M-22.1%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More ReShape Lifesciences, Inc. financials

Frequently Asked Questions

What was ReShape Lifesciences, Inc.'s revenue in fiscal year 2025?

ReShape Lifesciences, Inc. generated $320K in revenue in fiscal year 2025.

How fast is ReShape Lifesciences, Inc.'s revenue growing?

ReShape Lifesciences, Inc. (RSLS) revenue rose by 24.4% year over year, from $257K to $320K in fiscal year 2025.

How has ReShape Lifesciences, Inc.'s revenue changed over the years?

Across the 12 fiscal years this page covers, ReShape Lifesciences, Inc. (RSLS) revenue went from $3.5M in fiscal year 2014 to $320K in fiscal year 2025.

ReShape Lifesciences, Inc. (RSLS) reported $32K in revenue in Q1 2026. This represents a decrease of 84.1% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what ReShape Lifesciences, Inc. (RSLS) reported on that line in every period on record.